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MicroRNA-150 modulates 
intracellular Ca2+ levels in naïve 
CD8+ T cells by targeting TMEM20
Tae-Don Kim1,2, Hong-Ryul Jung1,3, Sang-Hwan Seo1, Se-Chan Oh1,2, Youngho Ban  4, 
Xiaoxia Tan5, Jung Min Kim6, Sang Hyun Lee  1, Duk-Su Koh7, Haiyoung Jung1,2, Young-Jun 
Park1,2, Suk Ran Yoon1,2, Junsang Doh3, Sang-Jun Ha4, Inpyo Choi1,2 & Philip D. Greenberg5
Regulation of intracellular Ca2+ signaling is a major determinant of CD8+ T cell responsiveness, but 
the mechanisms underlying this regulation of Ca2+ levels, especially in naïve CD8+ T cells, are not fully 
defined. Here, we showed that microRNA-150 (miR-150) controls intracellular Ca2+ levels in naïve 
CD8+ T cells required for activation by suppressing TMEM20, a negative regulator of Ca2+ extrusion. 
miR-150 deficiency increased TMEM20 expression, which resulted in increased intracellular Ca2+ levels 
in naïve CD8+ T cells. The subsequent increase in Ca2+ levels induced expression of anergy-inducing 
genes, such as Cbl-b, Egr2, and p27, through activation of NFAT1, as well as reduced cell proliferation, 
cytokine production, and the antitumor activity of CD8+ T cells upon antigenic stimulation. The 
anergy-promoting molecular milieu and function induced by miR-150 deficiency were rescued by 
reinstatement of miR-150. Additionally, knockdown of TMEM20 in miR-150-deficient naïve CD8+ T cells 
reduced intracellular Ca2+ levels. Our findings revealed that miR-150 play essential roles in controlling 
intracellular Ca2+ level and activation in naïve CD8+ T cells, which suggest a mechanism to overcome 
anergy induction by the regulation of intracellular Ca2+ levels.
Cluster of differentiation (CD) 8+ T cells act as key effector components in adaptive immunity by killing intracel-
lular pathogen-infected and transformed cells. To acquire effector activity, naïve CD8+ T cells require triggering 
via 1) interaction of the T cell receptor (TCR) with antigenic peptide-loaded major histocompatibility complexes, 
and 2) engagement of co-stimulatory molecules such as CD28. In the absence of co-stimulation, TCR-stimulated 
naïve CD8+ T cells cannot produce interleukin (IL)-2 and proliferate upon subsequent antigenic stimulation. This 
unresponsiveness of CD8+ T cells has been termed anergy1.
Activation, as well as anergy induction, of CD8+ T cells is associated with Ca2+-mediated signaling. TCR 
stimulation increases intracellular Ca2+ concentrations, which induce the nuclear localization of nuclear fac-
tor of activated T-cells 1 (NFAT1)2. Simultaneously, CD28 co-stimulation activates mitogen-activated protein 
kinase, which activates activator protein 1 (AP-1). Cooperation of NFAT1 with AP-1 induces expression of genes 
associated with T cell activation, such as IL-2, whereas NFAT1 activation without AP-1 initiates transcription of 
anergy-inducing genes, such as early growth-response protein 2 (Egr2) and p273, 4. Additionally, naïve T cells can 
acquire an anergic phenotype if the intracellular Ca2+ concentration is sustained at a high level before the TCR 
stimulation that accompanies co-stimulation, and such hypo-responsiveness can be normalized by blocking Ca2+ 
accumulation. Thus, variations in intracellular Ca2+ concentrations may contribute critically to the fate of T cells 
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and the regulation of intracellular Ca2+ levels in naïve CD8+ T cells should be tightly regulated to avoid T cell 
anergy5. However, the regulating mechanism of intracellular Ca2+ in naïve CD8+ T cells is not widely defined yet.
During CD8+ T cell activation, intracellular Ca2+ concentrations are primarily regulated by the calcium 
release-activated Ca2+ (CRAC) channel and plasma membrane Ca2+ ATPase (PMCA)6. TCR stimulation 
induces Ca2+ release from the endoplasmic reticulum (ER) through the inositol trisphosphate receptor, and the 
increased cytosolic Ca2+ level, in association with calmodulin, activates PMCA to extrude Ca2+ from the cell. 
The reduced Ca2+ concentration in the ER lumen, referred to as store depletion, triggers stromal-interacting 
molecule 1 (STIM1) to open the CRAC channel via interactions with CRAC channel protein 1 (ORAI1) in the 
plasma membrane. The opened CRAC channel causes an influx of extracellular Ca2+ into the cell7. Additionally, 
STIM1 inhibits PMCA-mediated Ca2+ removal from the cell8. The Ca2+-regulating activity of STIM1 is mediated 
by the formation of a complex with transmembrane protein 20 (TMEM20)9, followed by the translocation of 
the complex to the adjacent side of the plasma membrane, eventually enabling STIM1 to bind PMCA. Based on 
this Ca2+-regulating mechanism, TMEM20 appears to play a crucial role in CD8+ T cell activation that must be 
precisely regulated; however, the specific mechanism by which this occurs and the role in naïve CD8+ T cells are 
largely unknown.
microRNAs (miR) are noncoding RNAs about 22 nucleotides in length that mediate post-transcriptional gene 
regulation through translational repression and degradation of messenger RNA after binding to the 3′ untrans-
lated region (UTR) of the target RNA10. Based on this regulatory activity, miRNAs, including miR-150, are widely 
associated with the development and biological function of immune cells. During T cell development in the 
thymus, miR-150 represses neurogenic locus notch-homolog protein 3, a factor involved in T cell differentiation 
and survival, suggesting that miR-150 is one of the controlling factors for CD8+ T cell development11. Recently, 
miR-150 was also shown to be required for CD8+ T cell activation12, and miR-150-deficient CD8+ T cells showed 
reduced proliferation, differentiation into terminal effector cells, and acquisition of effector function required for 
killing infected cells. Changes in the transcriptome, such as a decrease in proliferation/killing-associated RNAs 
and an increase in inhibitory RNAs, were suggested as a molecular mechanism associated with hypo-functional 
cells; however, the specific mechanism, including the direct target of miR-150 and the molecular events that fol-
lowed antigenic stimulation in the absence of miR-150 in naïve CD8+ T cells, has not been elucidated.
In this study, we revealed that miR-150 is a critical factor in the prevention of an ectopic increase in intracel-
lular Ca2+ levels, which prevents anergy induction in naïve CD8+ T cells. Mechanistically, miR-150 suppresses 
increases in intracellular Ca2+ levels by directly suppressing TMEM20 expression. This miR-150-induced reduc-
tion in TMEM20 allows naïve CD8+ T cells to remove intracellular Ca2+ and eventually inhibits the expression 
of anergy-inducing genes, such as Casitas B lineage lymphoma b (Cbl-b), Egr2, and p27. These findings provide a 
specific molecular mechanism by which miR-150 regulates CD8+ T cell activation and affirms the central impor-
tance of intracellular Ca2+ regulation in naïve CD8+ T cells.
Results
miR-150 deficiency increases intracellular Ca2+ levels in naïve CD8+ T cells. Since the levels of 
miR-150 are relatively high in naïve CD8+ T cells and gradually decrease after TCR stimulation, miR-150 may be 
involved in regulating CD8+ T cell function13. Transferred miR-150-deficient (mir-150−/−) CD8+ T cells showed 
reduced proliferation in vivo (Fig. 1a) after antigen stimulation with recombinant Listeria-expressing gag Ag 
(Lm-gag), and they retained the characteristics of limited differentiation, including low expression of killer cell 
lectin-like receptor G1 (KLRG1), and high expression of CD127 (Fig. 1b). mir-150−/− CD8+ T cells also showed 
reduced function, in terms of decreased expression of effector-associated cytokines [IL-2, interferon-γ (IFN-γ), 
and granzyme B] and activation-/proliferation-associated molecules (cMyc, cyclin B1, T-bet, EOMES, Blimp1, 
IL-1β, Klrg1, Cdk6, Cdc23, and Cep120), compared with expression levels observed in mir-150+/+ CD8+ T cells 
(Fig. 1c and Fig. S1), which is consistent wit results in a previous report12. Notably, the expression of the aner-
gy-inducing gene (Egr2) increased in mir-150−/− CD8+ T cells (Fig. S1c). Additionally, the antitumor activity of 
CD8+ T cells decreased as a result of miR-150 deficiency (Fig. 1d). Collectively, these data suggested that miR-150 
is required for proliferation, differentiation, and cytolytic activity of CD8+ T cells.
To determine the molecular mechanism associated with reduced activation and functionality in mir-150−/− 
CD8+ T cells, we first measured intracellular Ca2+ levels, because a change in intracellular Ca2+ level is one of 
the initial events during CD8+ T cell activation. Naïve mir-150−/− CD8+ T cells cultured under physiological 
concentrations of Ca2+-containing media exhibited increased intracellular Ca2+ levels relative to those in naïve 
mir-150+/+ CD8+ T cells (Fig. 2a), and the increased intracellular Ca2+ levels in naïve mir-150−/− CD8+ T cells 
were sustained (Fig. S2)14. To determine the degree to which intracellular Ca2+ levels increased in naïve mir-
150−/− CD8+ T cells, we compared the levels in mir-150+/+ and mir-150−/− CD8+ T cells before and after TCR 
stimulation. The basal levels of intracellular Ca2+ in naïve mir-150−/− CD8+ T cells were already similar to the 
increased levels achieved in mir-150+/+ CD8+ T cells following TCR stimulation and were not further increased 
by TCR stimulation (Fig. 2b). These data suggested that miR-150 is required for regulation of intracellular Ca2+ 
levels in naïve CD8+ T cells.
miR-150 deficiency leads to expression of anergy-inducing genes through NFAT1 activation 
in naïve CD8+ T cells. Because increased intracellular Ca2+ levels in the absence of complete TCR signals 
are known to activate NFAT1, which can then activate anergy-inducing genes, we hypothesized that the reduced 
functionality of mir-150−/− naïve CD8+ T cells might be associated with ectopic activation of NFAT1 in naïve 
mir-150−/− CD8+ T cells2, 5, 15. Following incubation in physiological Ca2+ concentrations, naïve mir-150−/− 
CD8+ T cells showed increased nuclear localization of NFAT1 and active forms of NFAT1 (dephosphorylated 
NFAT1) (Fig. 3a,b). Additionally, naïve mir-150−/− CD8+ T cells expressed anergy-inducing genes such as Cbl-b, 
Src-homology region 2 domain-containing phosphatase-1 (SHP-1), Egr2, and p27, at higher levels than those 
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observed in naïve mir-150+/+ CD8+ T cells (Fig. 3b)4, 16–18. mRNA levels of anergy-inducing genes, such as SHP-1, 
Egr2, and p27 were also upregulated (Fig. 3c), and treatment with NFAT1 inhibitor (cyclosporine A) reduced the 
mRNA levels of anergy-related genes (Fig. 3d), indicating that upregulated expression of anergy-inducing genes is 
associated with NFAT1 activation in naïve mir-150−/− CD8+ T cells. Collectively, these results suggested that the 
reduction in naïve mir-150−/− CD8+ T cell function might be associated with the induction of a Ca2+-dependent 
anergy-inducing molecular milieu.
Elevation of intracellular Ca2+ levels in naïve mir-150−/− CD8+ T cells is associated with down-
regulated PMCA activity. Intracellular Ca2+ concentrations are regulated primarily by CRAC and PMCA6. 
Thus, we first investigated whether the elevated intracellular Ca2+ levels in response to miR-150 deficiency were 
associated with impaired CRAC activity using an inhibitor for CRAC, 2-aminoethoxydiphenyl borate (2-apb). 
Treatment with 2-apb suppressed the increasing speed in intracellular Ca2+ levels both in naïve mir-150+/+ and 
mir-150−/− CD8+ T cells (Fig. 4a). However, the intracellular Ca2+ levels in naïve mir-150+/+ CD8+ T cells after 
2-apb treatment were similar to those in untreated control CD8+ T cells, indicating that CRAC regulates Ca2+ 
uptake in naïve CD8+ T cells as it does in TCR-stimulated CD8+ T cells, but is not primarily associated with 
overall intracellular Ca2+ levels in naïve CD8+ T cells. Therefore, the intracellular Ca2+ levels elevated by mir-150 
deficiency are not associated with CRAC activity. We then investigated the relationship between the intracellular 
Ca2+ levels elevated by miR-150 deficiency and PMCA function by using two different inhibitors of PMCA activ-
ity, La3+ and 5(6)-carboxyeosin19, 20. La3+ treatment elevated intracellular Ca2+ levels in a dose-dependent manner 
in naïve mir-150+/+ CD8+ T cells, indicating that PMCA activity is crucial to regulating intracellular Ca2+ levels 
in naïve CD8+ T cells as it is in TCR-stimulated CD8+ T cells (Fig. 4b). The increased Ca2+ levels in naïve mir-
150+/+ CD8+ T cells after La3+ (1 mM) or 5(6)-carboxyeosin treatment were similar to those in untreated naïve 
mir-150−/− CD8+ T cells (Fig. 4b and Fig. S3). In the case of naïve mir-150−/− CD8+ T cells, the intracellular Ca2+ 
levels did not change after treatment with La3+ or 5(6)-carboxyeosin. In addition, the calculated Ca2+-reducing 
Figure 1. miR-150 deficiency decreases responsiveness to antigenic stimulation and antitumor activity of 
CD8+ T cells in vivo. (a) Kinetics of mir-150+/+ and mir-150−/− CD8+ T cells after antigenic stimulation in 
vivo. Thy1.1:TCRgag:mir-150+/+ or Thy1.1:TCRgag:mir-150−/− CD8+ T cells were transferred to Thy1.2 C57/BL6 
mice. The mice were injected with Lm-gag intraperitoneally. The transferred CD8+ T cells were analyzed using 
blood samples at 0, 5, 7, 12, and 54 d after the transfer. (b) Expression of surface markers in mir-150−/− and 
mir-150+/+ CD8+ T cells at 5 d after transfer and Lm-gag injection. (c) Relative mRNA amount of activation-
induced molecules in mir-150−/− and mir-150+/+ CD8+ T cells after stimulation for 5 h. (d) Antitumor activity 
of mir-150−/− and mir-150+/+ CD8+ T cells in vivo. Mice were injected intra-peritoneally with FBL-gag cell. At 
5 d after FBL injection, the mice were received cytoxan (Cyt) and 6 h later transferred mir-150+/+ or mir-150−/− 
CD8+ T cells. FBL; FBL injection, Cyt; FBL and Cyt injection, mir-150−/− or mir-150+/+; FBL, cyt and CD8+ T 
cell injection. *P < 0.05, **P < 0.01, ***P < 0.001. Data are means ± SEM of duplicate triplicate samples from a 
single experiment and are representative of two independent experiments.
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Figure 2. An increased intracellular Ca2+ level in naïve CD8+ T cells by miR-150 deficiency. (a) Comparison of 
intracellular Ca2+ levels in mir-150+/+ and mir-150−/− naïve CD8+ T cells after incubation in media containing 
2 mM Ca2+ (left) and intracellular Ca2+ levels at 15 min incubation (middle). For calcium tracing, single cell 
analyses were performed (sky blue line: mir-150+/+ CD8+ T cells and pink line: mir-150−/− CD8+ T cells) and 
data were represented with averages (blue line: mir-150+/+ CD8+ T cells and red line: mir-150−/− CD8+ T 
cells). Images are representative at 15 min after incubation (right). (b) The magnitude of increased intracellular 
Ca2+ level in mir-150−/− naïve CD8+ T cell. mir-150+/+ or mir-150−/− naïve CD8+ T cells were sequentially 
treated with anti-CD3-biotin and streptavidin at 4 and 5 min after incubation in Ca2+ containing media (up) 
and intracellular Ca2+ levels at 10 min incubation (down left). The images are the representatives at 10 min 
incubation (down right). *P < 0.05, **P < 0.01, ***P < 0.001, ns: not significant. Data are means ± SEM and are 
representative of two independent experiments.
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rates (Fig. 4b) in the untreated set (0 mM La3+) were lower in naïve mir-150−/− CD8+ T cells than those in naïve 
mir-150+/+ CD8+ T cells (Fig. S4), suggesting that PMCA activity might have been impaired in naïve mir-150−/− 
CD8+ T cells before treatment with the PMCA inhibitors.
Figure 3. miR-150 deficiency induces the expression of anergy-related genes in naïve CD8+ T cells. (a) The 
level of nuclear localization of NFAT1 in mir-150+/+ and mir-150−/− naïve CD8+ T cells after incubation under 
Ca2+ (2 mM) for at 20 min. The images are the representative samples (left) and the level of nuclear localization 
of NFAT1 (right). (b) The expression level of anergy-related genes and phosphorylation status of NFAT1 in 
naïve mir-150+/+ and mir-150−/− CD8+ T cells after incubation in 2 mM Ca2+ containing media (left) and the 
calculated expression levels (right). Western data are the cropped blot images representing indicated proteins. 
(c) Relative expression level of anergy-related and Egr2-related gene in mRNA levels in mir-150−/− naïve CD8+ 
T cells compared with those in mir-150+/+ naïve CD8+ T cells. (d) The effect of inhibition of NFAT translocation 
on the expression levels of anergy-related genes in mir-150+/+ and mir-150−/− naïve CD8+ T cells. Isolated mir-
150+/+ and mir-150−/− naïve CD8+ T cells were incubated with or without cyclosporine A (CsA, 3 µM) for 12 h 
and the amount of anergy-related mRNAs were measured using RT-PCR *P < 0.05, **P < 0.01, ***P < 0.001. 
Data are means ± SEM of duplicate triplicate samples from a single experiment and are representative of two 
independent experiments.
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Figure 4. Elevated intracellular Ca2+ levels in miR-150 deficient CD8+ T cells are caused by down-related 
PMCA activity. (a) Intracellular Ca2+ levels in mir-150+/+ or mir-150−/− naïve CD8+ T cells in the presence or 
absence of CRAC inhibitor (2-Aminoethoxydiphenyl borate, 2-APB) (left) and the intracellular Ca2+ levels at 
10 min incubation (middle). Images are the representatives at 10 min incubation (right). mir-150+/+ or mir-
150−/− naïve CD8+ T cells were incubated in 2 mM of Ca2+ containing medium in the presence or absence 
of 2-APB for 10 min and measured the intracellular Ca2+ levels from the cells. (b) Change in the intracellular 
Ca2+ level by treatment with PMCA inhibitor, La3+ (0.3, 0.5 or 1 mM), in mir-150+/+ and mir-150−/− naïve 
CD8+ T cells. mir-150+/+ and mir-150−/− naïve CD8+ T cells were cultures with 2 mM of Ca2+ containing 
medium and incubated in the presence or absence of indicated concentration of La3+ (up). Dot graph shows 
intracellular Ca2+ level at 15 min incubation (down left). Images are representatives for the intracellular Ca2+ 
level from the CD8+ T cells at 15 min incubation (down right). **P < 0.01, ***P < 0.001, ns: not significant. 
Data are means ± SEM of duplicate triplicate samples from a single experiment and are representative of two 
independent experiments.
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Mitochondrial calcium uniporter (MCU), sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) in the ER, and 
sodium-calcium exchanger (NCX) in the cellular membrane are also known as regulators of intracellular Ca2+ lev-
els21, 22. Thus, we also investigated whether these regulators are associated with increased intracellular Ca2+ levels in 
naïve mir-150−/− CD8+ T cells. Treatment with inhibitors of MCU (3 mM sodium cyanide + 2ug/ml oligomycin) or 
SERCA (1uM thapsigargin; TG) did not change intracellular Ca2+ levels in naïve mir-150+/+ CD8+ T cells (Fig. S5). 
In NCX-inhibited conditions using sodium-free media, intracellular Ca2+ levels in naïve mir-150+/+ CD8+ T cells 
were similarly unchanged. In naïve mir-150−/− CD8+ T cells, the intracellular Ca2+ levels did not change in MCU-, 
SERCA-, or NCX-inhibited conditions. Thus, MCU, SERCA, and NCX are not associated with overall intracellular 
Ca2+ levels in naïve CD8+ T cells, suggesting that increased intracellular Ca2+ levels in mir-150−/− CD8+ T cells are 
not associated with MCU, SERCA, and NCX. Collectively, these results suggested that increased intracellular Ca2+ 
levels in naïve mir-150−/− CD8+ T cells may be associated with impaired PMCA activity.
miR-150 facilitates PMCA function by downregulating TMEM20 expression. Because PMCA 
activity is negatively regulated by the STIM1-TMEM20 complex9, we investigated whether the impaired PMCA 
activity in mir-150−/− naïve CD8+ T cells was associated with altered expression of STIM1 and/or TMEM20. 
TMEM20 protein expression was upregulated in mir-150−/− naïve CD8+ T cells, but STIM1 and other 
Ca2+-regulation-associated molecules were unchanged (Fig. 5a). Confocal microscopic analysis also showed that 
TMEM20 expression was higher and co-localization of TMEM20 with PMCA was greater in naïve mir-150−/− 
CD8+ T cells than those in naïve mir-150+/+ CD8+ T cells (Fig. 5b and Fig S6). Interestingly, TMEM20 did 
not seem to co-localize with STIM1 in both naïve mir-150+/+ and mir-150−/− CD8+ T cells, indicating that the 
increased intracellular Ca2+ levels in mir-150−/− CD8+ T cells were not associated with STIM1. Thus, TMEM20 
may suppress PMCA activity in a STIM1-independent manner in naïve mir-150−/− CD8+ T cells.
To assess the potential for miR-150 to suppress TMEM20 expression specifically, we performed an arylalky-
lamine N-acetyltransferase (AANAT)-reporter assay as previously described23, 24. Based on the miRanda algo-
rithm (www.microrna.com), the 3′UTR of TMEM20 mRNA contains a putative binding sequence for miR-150 
(Fig. 5c), and overexpression of miR-150 reduced the expression of the AANAT reporter protein but not AANAT 
Figure 5. miR-150 specifically binds to 3′UTR of TMEM20 and down-regulates TMEM20 expression. (a) 
The expression level of Ca2+-associated molecules in mir-150+/+ and mir-150−/− naïve CD8+ T cells (left). The 
relative amount of TMEM20 mRNA in mir-150+/+ and mir-150−/− naïve CD8+ T cells (right). Western data are 
the cropped blot images representing indicated proteins. (b) Co-localization of STIM1, TMEM20 and PMCA 
in mir-150+/+ and mir-150−/− naïve CD8+ T cells (up) and the fluorescence intensity for each molecules on the 
line (down). Green; PMCA, Red; STIM1, Purple; TMEM20. (c) Post-transcriptional regulation of miR-150 by 
targeting 3′UTR of TMEM20. miR-150 binding sequences of TMEM20 3′UTR (left up). The level of AANAT 
protein (left down) and mRNA (right) in NIH3T3 cells co-transfected with plasmid-expressing AANAT 
reporter containing TMEM20 3′UTR and miR-150 or miR-150 mutant. Western data are the cropped blot 
images representing indicated proteins. *P < 0.05. Data are means ± SEM of duplicate triplicate samples from a 
single experiment and are representative of two independent experiments.
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mRNA. In contrast, forced expression of a miR-150 mutant incapable of binding to the TMEM20 3′UTR did not 
change AANAT expression, suggesting that miR-150 suppresses the expression of TMEM20, and has the potential 
to do so directly.
miR-150 restoration recovers the miR-150 phenotype in miR-150-deficient CD8+ T cells. We 
then investigated whether miR-150 restoration could recover intracellular Ca2+ levels and the molecular signa-
ture in naïve mir-150−/− CD8+ T cells. We infected naïve mir-150−/− CD8+ T cells with a retrovirus-expressing 
miR-150 (retro-miR-150) and analyzed the resulting cell phenotype. miR-150 restoration increased miR-150 
levels in CD8+ T cells (Fig. 6a). Furthermore, retro-miR-150 infection reduced intracellular Ca2+ levels in mir-
150−/− CD8+ T cells to levels observed in mir-150+/+ CD8+ T cells (Fig. 6b). However, intracellular Ca2+ levels in 
mir-150+/+ CD8+ T cells were unchanged by the additional expression of miR-150, whereas TMEM20 expression 
in mir-150−/− CD8+ T cells was reduced by restoration of miR-150 (Fig. 6c). Additionally, retro-miR-150 infec-
tion of mir-150−/− CD8+ T cells reduced expression of anergy-related genes Cbl-b, Egr2, and p27 and increased 
the expression of activation-induced molecules granzyme B, cyclin B1, and Blimp1 following anti-CD3/CD28 
stimulation (Fig. 6c,d). In addition, suppression of TMEM20 expression by infection with small interfering RNA 
targeting TMEM20 (siTMEM20) decreased intracellular Ca2+ levels in naïve mir-150−/− CD8+ T cells, indicating 
that the balance between TMEM20 and miR-150 regulates intracellular Ca2+ levels in naïve CD8+ T cells (Fig. 6e). 
These data suggested that miR-150 is required for activation of naïve CD8+ T cells by regulating intracellular Ca2+ 
levels and preventing the expression of anergy-related genes (Fig. 6f).
Discussion
In CD8+ T cells, increasing the concentration of intracellular Ca2+ after TCR stimulation is essential to inducing 
the expression of activation-associated genes2, 25, 26. Because controlling the Ca2+ concentration is crucial for T cell 
activation, there has been an extensive search for molecules, such as channels, transporters, and other proteins, 
Figure 6. Add-back of miR-150 rescues Ca2+ homeostasis and inhibits expression of anergy-related genes 
in mir-150−/− naïve CD8+ T cells. (a) Isolated mir-150+/+ naïve CD8+ T cells were infected with 10 MOI of 
retrovirus co-expressing miR-150 and GFP (retro-miR-150-gfp) and the miR-150 levels were analyzed. (b) 
Intracellular Ca2+ levels in retro-miR-150 transduced or control mir-150+/+ or mir-150−/− naïve CD8+ T cells 
(left). Dot graph shows intracellular Ca2+ levels at 15 min incubation (middle) and the representative images 
(right). (c) Expression levels of TMEM20 and anergy-related genes after add-back of miR-150 by transduction 
of retro-miR-150 in mir-150−/− naïve CD8+ T cells. (d) Relative expression level of granzyme B, cyclinB1 and 
Blimp1 after stimulation using anti-CD3/CD28 in mir-150−/− CD8+ T cells and retro-miR-150 infected mir-
150−/− CD8+ T cells. (e) TMEM20 mRNA amount (up left) and intracellular Ca2+ levels (up right) in siRNA 
for TMEM20 or control-siRNA transfected mir-150−/− naïve CD8+ T cells (left). Dot graph shows intracellular 
Ca2+ levels at 10 min incubation (down left) and representative images (down right) (f) Schematic cartoon 
for the effect of miR-150 on Ca2+ homeostasis and induction of anergy-related genes in naïve CD8+ T cells. 
*P < 0.05, **P < 0.01, ***P < 0.001, ns: not significant.
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associated with Ca2+ movement during T cell activation. The preconditions for increasing intracellular Ca2+ levels 
during T cell activation are a relatively low level of intracellular Ca2+ in naïve CD8+ T cells and an ectopic increase 
in intracellular Ca2+ levels before T cell activation turns T cells into tolerant cells5. Although controlling intra-
cellular Ca2+ levels in naïve CD8+ T cells is also critical for T cell activation, regulatory molecules and associated 
mechanisms that determine the Ca2+ level in naïve CD8+ T cells are largely unknown. In this study, we showed 
that miR-150 controls intracellular Ca2+ levels by downregulating TMEM20 expression in naïve CD8+ T cells. 
The miR-150-induced suppression of TMEM20 expression prevented the expression of anergy-inducing genes 
and hypo-responsiveness of CD8+ T cells upon antigenic stimulation. Therefore, miR-150 is an essential regulator 
that creates an activation-favorable molecular milieu in naïve CD8+ T cells.
In this study, we showed that intracellular Ca2+ levels are increased by miR-150 deficiency in naïve CD8+ T 
cells. In mir-150−/− naïve CD8+ T cells, the expression level of TMEM20 was increased, while expression levels of 
other Ca2+ regulating molecules did not changed. In addition, suppression of TMEM20 decreased intracellular 
Ca2+ levels in mir-150−/− naïve CD8+ T cells, indicating that the increased intracellular Ca2+ levels in mir-150−/− 
naïve CD8+ T cells are derived from the increased expression of TMEM20. Previous report showed that TMEM20 
attenuates PMCA activity9. mir-150−/− naïve CD8+ T cells showed high translocation of TMEM20 into PMCA in 
plasma membrane. In addition, Ca2+ reducing rate also decreased in mir-150−/− naïve CD8+ T cells. Treatment 
of PMCA inhibitor did not changed the intracellular Ca2+ level in mir-150−/− naïve CD8+ T cells whereas treat-
ment of inhibitors for other Ca2+-regulating molecules changed the intracellular Ca2+ levels in mir-150−/− naïve 
CD8+ T cells, which also can be an indirect clue that PMCA activity is inactivated in mir-150−/− naïve CD8+ T 
cells. Collectively, the high Ca2+ levels in mir-150−/− naïve CD8+ T cells are derived from increased expression of 
TMEM20, thereby inactivation of Ca2+ extruding PMCA activity.
Several regulators such as PMCA, CRAC, SERCA, NCX, and MCU control intracellular Ca2+ levels in 
TCR-stimulated CD8+ T cells22, 27. In this study, we showed that PMCA, but not other regulators, mainly con-
trols intracellular Ca2+ levels in naïve CD8+ T cells. Although CRAC inhibition slowed the Ca2+ uptake rate in 
naïve CD8+ T cells, overall intracellular Ca2+ levels were not changed, indicating that the role of CRAC is limited 
to regulating intracellular Ca2+ level in naïve CD8+ T cells. The unchanged intracellular Ca2+ levels in naïve 
CD8+ T cells in SERCA- and NCX-inactivated conditions could be a result of Ca2+-regulating activity that is 
TCR-activation dependent. For MCU, their Ca2+-regulating function is associated with relocation of mitochon-
dria. In TCR-stimulated T cells, mitochondria relocate to the immunological synapse, where the mitochondria 
act as Ca2+-controlling machinery through MCU21. Un-polarized mitochondria at the sites of Ca2+ influx in naïve 
CD8+ T cells might be a reason that MCU is not associated with intracellular Ca2+ levels in naïve CD8+ T cells.
In a previous study, TMEM20-mediated suppression of PMCA activity was shown to be dependent on 
calcium store depletion in the ER and co-localization with STIM1 in a Jurkat cell line model9. However, our 
co-localization data showed that TMEM20 does not co-localize with STIM1 either in naïve mir-150+/+ or 
mir-150−/− CD8+ T cells. In addition, the expression levels of STIM1 were similar between naïve mir-150+/+ 
and mir-150−/− CD8+ T cells. Considering the increased intracellular Ca2+ levels in naive mir-150−/− CD8+ T 
cells, STIM1 does not act as a regulator of intracellular Ca2+ in naïve CD8+ T cells. Thus, PMCA may act in a 
STIM-independent manner in naïve CD8+ T cells. Given that mir-150 has many targets, expression of undefined 
factor(s) supporting TMEM20 function could be increased in naïve mir-150−/− CD8+ T cells, and, thereby, the 
increase in TMEM20 with the associated factor(s) might suppress PMCA activity in naïve mir-150−/− CD8+ T 
cells before calcium store-depletion in the ER. Another possible mechanism for calcium store depletion inde-
pendent of TMEM20-mediated PMCA deactivation is TMEM20 expression in the plasma membrane, which 
might deactivate PMCA function itself, but its function could also be limited by insufficient expression to act in 
naïve mir-150+/+ CD8+ T cells. In this case, increased TMEM20 expression in naïve mir-150−/− CD8+ T cells may 
be sufficient to deactivate PMCA function, resulting in the increase in intracellular Ca2+ levels in naïve mir-150+/+ 
CD8+ T cells.
The expression levels of TMEM20 mRNA were similar between naïve mir-150+/+ and mir-150−/− CD8+ T 
cells. However, retroviral-mediated overexpression of miR-150 downregulated the expression of TMEM20 
mRNA. Considering that miR-150 levels in retro-miR-150-infected mir-150+/+ CD8+ T cells were more than 
2-fold higher than those in the uninfected control mir-150+/+ CD8+ T cells, retro-miR-150 infected mir-150−/− 
CD8+ T cells may have higher levels of miR-150 than those in mir-150+/+ CD8+ T cells. Thus, it is possible that a 
normal amount of miR-150, such as that in naïve mir-150+/+ CD8+ T cells, might repress translation of TMEM20, 
whereas overexpression of miR-150, such as that in retro-miR-150 infected naïve mir-150−/− CD8+ T cells, might 
suppress transcription of TMEM20. Given that miR-150 has many targets, miR-150 overexpression might induce 
suppression of TMEM20 as well as have additional or alternative effects, and the additional effects, not suppres-
sion of TMEM20 levels, could be the reason for the decreased intracellular Ca2+ levels in retro-miR-150-infected 
naïve mir-150−/− CD8+ T cells. However, we showed that suppression of TMEM20 expression decreased the 
intracellular Ca2+ levels in naïve mir-150−/− CD8+ T cells. Thus, TMEM20 expression levels, especially in the 
absence of miR-150, are critical to controlling intracellular Ca2+ levels in naïve CD8+ T cells.
Whether simply overexpressing TMEM20 is sufficient to increase intracellular Ca2+ levels in naïve mir-
150+/+ CD8+ T cells in questionable. In a previous report, TMEM20 overexpression did not change the intra-
cellular Ca2+ levels in HEK 293 cells expressing STIM1 and Orai1 in thapsigargin-treated conditions, but 
thapsigargin-untreated conditions were not tested9. Although we showed that miR-150 deficiency did not change 
the expression levels of Ca2+-regulating molecules, except for TMEM20, miR-150 deficiency may influence unde-
fined factor(s) required for TMEM20 function, as described above. In this case, simply overexpressing TMEM20 
might not increase intracellular Ca2+ level in naïve mir-150+/+ CD8+ T cell. To date, the mechanism of TMEM20 
function and its associated/regulating molecules have not been widely investigated. Thus, studies on the mecha-
nism of TMEM20 function and regulation should be conducted to better understand the detailed mechanism of 
Ca2+ regulation in naïve CD8+ T cells before and after activation.
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miR-150 deficiency reduces CD8+ T cell activation, in terms of expansion, differentiation, and cytolytic func-
tion12. Although changes in the levels of several mRNAs in response to miR-150 deficiency were suggested in 
a previous study to be a mechanism for the observed reduction in CD8+ T cell activation, a direct relation-
ship between altered mRNA levels and CD8+ T cell activation-associated molecular changes was not found. 
In this study, we showed that TMEM20 is a direct target for miR-150 in naïve CD8+ T cells and that the miR-
150 deficiency-induced reduction in CD8+ T cell activation results from altered intracellular Ca2+ levels. In the 
absence of miR-150, elevated expression of TMEM20, a Ca2+ extruder, attenuates PMCA activity, resulting in 
increased intracellular Ca2+ levels in naïve CD8+ T cells8, 9. This increased intracellular Ca2+ induced activation 
of NFAT1, which consequently induced expression of anergy-inducing genes such as Egr2, Cbl-b, and p2716, 17, 
28. Because anergy-inducing genes such as p27 and Egr2 are reportedly miR-150 targets, increased expression of 
p27 and Egr2 in mir-150−/− CD8+ T cells may be a result of the loss of translational suppression of these mRNAs 
by miR-150 in mir-150−/− naïve CD8+ T cells29, 30. However, following treatment with an NFAT1 inhibitor, mir-
150−/− naïve CD8+ T cells showed decreased levels of p27 and Egr2 mRNA, indicating that increased expression 
of anergy-inducing genes is primarily due to transcriptional regulation via the intracellular Ca2+/NFAT1 signal-
ing pathway. Expression of these anergy-inducing genes related to miR-150 deficiency could explain the reduced 
proliferation, differentiation, and killing activity of naïve mir-150−/− CD8+ T cells upon antigenic stimulation, 
as previously reported12 and shown in our study. To avoid these miR-150-deficiency-induced molecular events, 
intracellular Ca2+ levels need to be sufficiently low to prevent NFAT1 activation.
It was previously reported that in effector CD8+ T cells, miR-150 levels are lower than in naïve CD8+ T cells13. 
Given that miR-150 suppresses expression of CD25, an IL-2 receptor, reduced miR-150 levels in effector CD8+ 
T cells can favor survival and proliferation31. Relatively low levels of miR-150 in effector CD8+ T cells may also 
be explained by intracellular Ca2+-associated events. Because miR-150 deficiency elevated intracellular Ca2+ lev-
els, decreased levels of miR-150 in effector CD8+ T cells implies that effector CD8+ T cells may require higher 
intracellular Ca2+ concentrations to promote activity such as that of cytotoxic T lymphocytes (CTLs). Previous 
reports showed that intracellular Ca2+ is involved in granule reorientation toward the target cell contact region 
and exocytosis of granules32–34. Additionally, intracellular Ca2+ mediates the production of effector cytokines and 
the expression of death receptor ligands35–37. To mediate these diverse functions associated with CTLs, high intra-
cellular Ca2+ concentrations may be required, which might be satisfied by miR-150 downregulation in effector 
CD8+ T cells.
miR-150 acts as a “fine tuner” of various immune cells. In B cells, miR-150 controls differentiation and recep-
tor signaling38–40. In natural killer cells, miR-150 regulates development, as well as cytotoxicity24, 41. T cell dif-
ferentiation and the expression of cytokine receptors are also influenced by miR-15011, 31. Here, we showed that 
miR-150 controlled Ca2+ signaling and prevented the induction of anergy in naïve CD8+ T cells. Considering 
these various roles for miR-150 in immune cells and various target molecules, studies to determine additional 
miR-150 roles in the immune system will likely shed light on currently undefined mechanisms as well as possible 
therapeutic approaches using CD8+ T cells.
Given the impact of miR-150 on CD8+ T cell activation, regulation of miR-150 expression may be a therapeu-
tic target in CD8+ T cell-associated diseases. Because we showed that mir-150−/− naïve CD8+ T cells could not be 
activated, CD8+ T cell-specific suppression of miR-150 expression may be a novel approach to treating autoim-
mune diseases. In this context, our findings indicate a molecular mechanism that prevents the transition of CD8+ 
T cells into a hypo-responsive state, as well as a basis for regulation of CD8+ T cell activation.
Methods
Mice. TCRgag transgenic mice have been generated as previously described42. C57BL/6 (B6) mice and mir-
150−/− mice on a B6 background were purchased from The Jackson Laboratory and TCRgag:mir-150+/+ and 
TCRgag:mir-150−/− mice were generated in our animal facility. All mice were bred and maintained under Specific 
Pathogen Free conditions. All of the methods and experimental procedures were conducted according to the 
approved (approval ID: KRIBB-AEC-15088) guidelines and regulations by the animal ethics committee (IACUC) 
of KRIBB, South Korea.
Cell lines. The Friend virus-induced erythroleukemia of B6 origin, FBL, expresses the FMuLV-encoded gag 
epitope (peptide CCLCLTVFL purchased from Pi Proteomics), and was maintained in culture in RPMI1460 
supplemented with 10% FBS and antibiotics. NIH3T3 cells for plasmid transfection were cultured in DMEM 
supplemented with 10% FBS and antibiotics.
Expansion of effector TCRgag CD8+ T cells in vitro. TCRgag:mir-150+/+ and TCRgag:mir-150−/− CD8+ 
T cells (1 × 106) were cultured with irradiated syngeneic splenocytes (5 × 106), irradiated FBL-gag leukemia 
(3 × 106), and IL-2 (20 U/ml) in RPMI 1640 supplemented with 2 μM glutamine, 100 U/ml penicillin/streptomy-
cin, 10% FCS, and 30 μM 2-mercaptoethanol. Effector CD8+ T cells after five days following antigen stimulation 
were used in various assays or transferred for adoptive immunotherapy.
T cell proliferation in vivo. Thy1.1+ CD8+ donor cells (1 × 106) from TCRgag:mir-150+/+ and 
TCRgag:mir-150−/− mice were transferred into Thy1.2+ B6 recipients. At one day after the transfer, the mice 
were injected with recombinant attenuated (ΔactA, ΔinlB) Listeria monocytogenes expressing the FMuLV GAG 
epitope (CCLCLTVFL) (Lm-gag) or a control vector (Lm-Ø) (kindly provided by Aduro BioTech, Inc) intraperi-
toneally. T cell persistence and proliferation were monitored in peripheral blood.
Immunofluorescence. Glass coverslips-attached cells were stimulated with CaCl2, PMA/Ionomycin, and 
anti-CD3 for indicated time points, washed using PBS, fixed in 3.7% formaldehyde for 10 min at 37 °C, perme-
abilized with 0.2% Triton X-100 for 10 min at room temperature, washed, and then blocked in 1% BSA in PBS 
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for 30 min. To visualize NFAT1, the cells were stained with anti-NFAT1 (Abcam) for 1 h, washed and incubated 
with FITC-conjugated anti-mouse antibody (Santa Cruz Biotechnology) for 1 h. Images were captured with an 
Olympus DP30BW digital camera and processed using the Metamorph 7.1 program (Universal Imaging, Media, 
PA, USA). Nuclear translocation of NFAT1 was measured by percentage of NFAT1 localized in the nucleus.
Adoptive immunotherapy of disseminated FBL leukemia. B6 mice were injected with FBL-gag leu-
kemia cells (5 × 106) intraperitoneally (i.p.) as described16. At 5 days later, mice received cytoxan (Cyt; 180 mg/kg, 
R&D systems) i.p., and 6 h later, received TCRgag:mir-150+/+ or mir-150−/− effector CD8+ T cells intravenously.
Measurement of intracellular Ca2+ in CD8+ T cells. CD8+ T cells were loaded with 2 μM fura-2/
AM (Life Technologies) for 20 min at 37 °C and attached to poly-L-lysine treated glass cover slips loaded 
in a Chamlide magnetic chamber (Live Cell Instrument) under Ca2+-free HSBB medium. The fura-2 loaded 
cells were perfused using HBSS medium containing 2 mM Ca2+. Cell images were obtained on a Zeiss Axio 
Observer.Z1 epifluorescence microscope. Fura-2 emission was detected at 510 nm after excitation at 340 and 
380 nm. In some experiments, biotin-conjugated anti-CD3 (5 μg/ml, 2C11, BioXCell), anti-CD28 (5 μg/ml, 
37.51, BioXCell) and streptavidin (10 μg/ml, Thermo Scientific) were added at the indicated time. To meas-
ure intracellular Ca2+ concentration in the CRAC, PMCA, SERCA, or MCU inhibited conditions, CD8+ 
T cells were pre-treated with specific inhibitors as below and measured intracellular Ca2+ levels as described 
above. CRAC inhibitor: 2-aminoethoxydiphenyl borate (2-APB, 100 uM, Sigma-Aldrich), PMCA inhibitors: 
La3+ (0.3, 0.5 or 1 mM, Sigma-Aldrich) and 5(6)-carboxyeosin (20 uM, AXXORA), SERCA inhibitor: thapsi-
gargin (1 µM, Sigma-Aldrich), MCU inhibitor: sodium cyanide (3 mM, Sigma-Aldrich) + oligomycin (2 µg/
mL, Sigma-Aldrich). For NCX inhibition, Na-free media (ThermoScientific) was used. Acquired time-lapse 
images and Fura 340/380 ratio images were analyzed with ImageJ software (National Institutes of Health) and 
Metamorph (Molecular Devices).
Flow cytometry. All antibodies for flow cytometric analysis were purchased from Becton Dickinson or BD 
Pharmingen. CD8+ T cells were stained with the indicated antibodies in a staining buffer (PBS containing 1% FBS 
and 0.01% NaN3) for 20 minutes at 4 °C. After washing, flow cytometry was performed on a BD FACS Canto II 
and data analyzed with FlowJo software (Tree Star).
Immunoblot analysis. Cytoplasmic lysates of CD8+ T cells were extracted with PBS containing 1% NP-40 
and complete proteinase inhibitor (Roche). Immunoblot analyses were performed with primary antibodies 
purchased from Abcam (anti-ITCH and anti-Egr2), Cell Signaling (anti-Calcineurin A, anti-NFAT1, anti-p27, 
and anti-STIM1), Santa Cruz Biotech (anti-Calcineurin B, anti-Cbl-b, anti-SHP-1, and anti-TMEM20), GenTex 
(anti-Orai1), Thermo Scientific (anti-P2X7) and AbFRONTIER (anti-GAPDH) and gifted from Dr. Klein DC 
(anti-AANAT). The secondary antibodies were visualized using an Immobilon Western kit (MILLIPORE).
Reverse transcription and quantitative PCR. Total RNA extracted with TRIzol (Invitrogen) was reverse 
transcribed with Moloney murine leukemia virus reverse transcriptase and oligo-d(T). For real-time qPCR, 
cDNA was amplified with specific primers and SYBR Premix Ex Taq (Takara Bio) on a Dice TP800 Thermal 
Cycler (Takara Bio). The mRNA levels are presented relative to expression of GAPDH mRNA. Quantitative 
real-time PCR of mature miR was performed with a TaqMan MicroRNA Assay kit (Applied Biosystems) as previ-
ously described23, 24. miR expressions are presented relative to the level of U6 small nuclear RNA.
mRNA array and data analysis. To collect naïve, effector, and memory CD8+ T cells, mice infected with 
Lm-gag as described in “T cell proliferation in vivo”, samples were isolated from the spleen at day 0, 5, and 50 
after Lm-gag infection, respectively, and analyzed the phenotype of each samples (naïve: CD8+CD44loCD62Lhi, 
effector: CD8+CD44hiCD62Llo, and memory: CD8+CD44hiCD62Lhi). Labeling of target mRNAs and hybridi-
zation were performed using Agilent’s mRNA Labeling Reagent and Hybridization Kit (Agilent Technology) as 
manufacturer’s instruction. The hybridization images were analyzed with an Agilent DNA microarray Scanner 
and quantified by using Agilent Feature Extraction software. Normalization and selection of all data were per-
formed by using GeneSpring GX 7.3 (Agilent Technology). For microarray data, genes were filtered with remov-
ing flag-out genes in each experiment. In the gene expression microarray, intensity-dependent normalization 
(LOWESS) was performed, where the ratio was reduced to the residual of the Lowess fit of the intensity vs. ratio 
curve. The averages of normalized ratios were calculated by dividing the average of normalized signal channel 
intensity by the average of normalized control channel intensity. Functional annotation of genes was performed 
according to Gene OntologyTM Consortium (http://www.geneontology.org/index.shtml) by GeneSpring GX 7.3. 
Gene classification was based on searches done by GeneCards (http://www.genecards.org/), miRanda (http://
www.microrna.org/), DAVID (http://david.abcc.ncifcrf.gov/), and Medline databases (http://www.ncbi.nlm.nih.
gov/). The microarray data can be accessed from the Gene Expression Omnibus under the accession GSE62262.
Plasmids and Reporter assay. To construct chimeric reporter plasmids pcAANAT-TMEM20, 3′UTR 
of the mouse TMEM20 was amplified by DNA polymerase (TAKARA) using specific primers (forward: 
5′-AAGAATTCTGAAGTGTCACTGCTGA-3′ and reverse: 5′-AACTCGAGAGTTGTAAAACCCA-ACA-3
′) and confirmed by sequencing. For AANAT reporter assays, NIH3T3 cells were co-transfected with 1 µg of 
pcAANAT- TMEM20 plasmids with one of either the miR-150 mimics, miR-150 mutants, or the non-targeting 
control (BiONEER) at concentrations of 50~100 nM using TransIT-X2 (Mirus Bio LLC). Transfected cells were 
further grown for 48 h before harvesting.
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Co-localization measurement of STIM1, PMEM20, and PMCA. Isolated CD8+ T cells were incu-
bated in the presence of 2 mM of Ca2+, fixed with paraformaldehyde (Sigma-Aldrich), permeabilized using Triton 
X-100 (Sigma-Aldrich) and stained with anti-PMCA (Abcam), anti-TMEM20 (SantaCruz Biotechnology) or 
anti-STIM1 (Cell Signaling Technology) antibody. Then the samples were stained with anti-rabbit IgG-Alex 
Fluor® 488, anti-rabbit-IgG-Alex Fluor® 546 or IgG-Alex Fluor® 647 (Life Technologies, Gaithersburg, MD) 
for PMCA, STIM1 or TMEM20, respectively. The images were obtained using LSM 510 META Laser Scanning 
Microscopes (Carl Zeiss).
Retrovirus preparation and transduction. pMXs-miR-GFP/puro retroviral expression vector was pur-
chased from Cell Biolabs, Inc. To generate pMXs-miR-150-GFP, miR-150 was amplified by RT-PCR from sple-
nocyte using primers as below: miR-150 forward primer containing XhoI site, 5′-TCG ACT CGA GAC AGG 
AAC CCC CTC CCT CAG C-3′; miR-150 reverse primer with XhoI site, 5′-TCG ACT CGA GGG AAG GGA 
CCC AAG GCA TCC C-3′. The amplified PCR product was cloned into pMXs-miR-GFP/puro after treatment 
with XhoI restriction enzyme. Retroviruses were generated using TransIT transfection reagents and Platinum-E 
retroviral packing cell line as manufacturer’ protocol (Mirus Bio Corp., Madison, WI). To add-back miR-150 to 
CD8+ T cells, 1 × 106 CD8+ T cells were transduced with multiplicity of infection of 10 of retro-miR-150-GFP 
or retro-miR-GFP with polybrene (8 μg/mL, Sigma-Aldrich) and IL-2 (10 U/mL, R&D systems). To measure the 
expression levels of anergy related genes after miR-150 add-back, CD8+ T cells were harvested at 2 d after virus 
infection and GFP-positive and negative populations were sorted using a FACS Aria cell sorter (BD Biosciences) 
and performed qPCR. For measurement of granzyme B, cyclin B1 and Blimp1, sorted GFP-positive and negative 
populations were incubated with anti-CD3/anti-CD28 (Life Technology) for 4 h, and PCR performed.
TMEM20 knock-down study. For TMEM20 knockdown, isolated mir-150−/− naïve CD8+ T cells were trans-
fected with 300 pmol of siRNA (none, control, or TMEM20: CGCTGGAGTGATACTTATCGTGAGACCAC) 
using Amaxa nucleofector (Lonza). At 48 hr after transfection, the cells were harvested and used to measure 
TMEM20 mRNA levels and intracellular Ca2+ levels as described above.
Statistical analysis. Bar graphs are displayed as mean ± SEM. Statistical analyses were performed with 
Prism version 5.0 (GraphPad Software) using an unpaired two-tailed Student’s t-test or Kaplan-Meier log-rank 
test for survival analysis. A p value < 0.05 was considered statistically significant.
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